Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Announcing two separate strategic China initiatives...
WuXi PharmaTech reported that a former China employee has...
Mindray Medical paid $35.5 million for a controlling...
Continuing a history of strong earnings reports, WuXi...
Hangzhou Tigermed Consulting, a clinical-stage CRO,...
WuXi PharmaTech signed a contract manufacturing agreement...
WuXi PharmaTech and Open Monoclonal Technology of...
China National Biotec announced that its upcoming Hong...
WuXi AppTec has formed a drug development JV with...
WuXi AppTec and MedImmune, an AstraZeneca subsidiary,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China